Related Experiment Video
Updated: Jul 5, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.9K
Sonothrombolysis: State-of-the-Art and Potential Applications in Children
Rebecca E Ward1,2, Santiago Martinez-Correa1, Luis Octavio Tierradentro-García1,2
1Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Children (Basel, Switzerland)
|January 23, 2024
Summary
Therapeutic ultrasound, or sonothrombolysis, shows promise for dissolving blood clots in children. More research is needed to confirm its safety and effectiveness in this young population.
Area of Science:
- Medical Science
- Biomedical Engineering
Background:
- Therapeutic ultrasound advances are established in adults.
- Pediatric applications of therapeutic ultrasound require further investigation.
Purpose of the Study:
- To review current pediatric research on sonothrombolysis.
- To characterize the utilization and practicality of sonothrombolysis in juveniles.
Main Methods:
- Literature review of PubMed database.
- Included clinical and preclinical studies on sonothrombolysis in pediatrics.
Main Results:
- Sonothrombolysis, especially with microbubbles, is effective and safe for clot dissolution in vitro and in animal models.
- Potential applications include deep venous thrombosis, ischemic stroke, and pulmonary embolism.
- Limited pediatric data exists due to lower thrombotic event prevalence.
Conclusions:
- Sonothrombolysis presents a potential noninvasive treatment for pediatric thrombotic events.
- Further pediatric research is crucial to address safety and ethical considerations.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K

